FDA Approved: ACETYLCYSTEINE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Acetylcysteine from Fresenius Kabi USA, LLC, under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acetaminophen Overdose
• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Cystic Fibrosis

Drugs mentioned

• Acetylcysteine (Acetylcysteine)

Snippet

SUPPL AP for ACETYLCYSTEINE (ACETYLCYSTEINE)